Colin Collins
19Patents
8h-index
20Co-inventors
72Inventor score
Filing activity: Oct 20, 1995 → Jul 15, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6664057B2 | Amplicon in the 20q13 region of human chromosome 20 and uses thereof | Chemistry; Metallurgy | 26 | Expired |
| US5801021A | Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer | Chemistry; Metallurgy | 21 | Expired |
| US7648826B1 | Detecting CYP24 expression level as a marker for predisposition to cancer | Emerging Cross-Sectional Technologies | 21 | Expired |
| US6465182B1 | Comparative fluorescence hybridization to oligonucleotide microarrays | Chemistry; Metallurgy | 19 | Expired |
| US6808878B1 | Genes from the 20Q13 amplicon and their uses | Chemistry; Metallurgy | 19 | Expired |
| US6358683B1 | Blood-based assays for breast cancer | Chemistry; Metallurgy | 16 | Expired |
| US6268184A | Amplifications of chromosomal region 20q13 as a prognostic indicator breast cancer | Chemistry; Metallurgy | 16 | Expired |
| US5892010A | Genes from the 20Q13 amplicon and their uses | Chemistry; Metallurgy | 15 | Expired |
| US8173602B2 | Detecting CYP24 expression level as a marker for predisposition to cancer | Emerging Cross-Sectional Technologies | 8 | Active |
| US6785614B1 | End sequence profiling | Chemistry; Metallurgy | 7 | Expired |
| US7049424B2 | Genes from the 20Q13 amplicon and their uses | Chemistry; Metallurgy | 6 | Expired |
| US7413899B2 | Genes from the 20q13 amplicon and their uses | Chemistry; Metallurgy | 4 | Expired |
| US7455964B1 | Genes from the 20q13 amplicon and their uses | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7482123B2 | Biomarkers for prostate cancer metastasis | Chemistry; Metallurgy | 2 | Expired |
| US7811986B2 | Genes from the 20Q13 amplicon and their uses | Chemistry; Metallurgy | 2 | Active |
| US8101370B2 | Genes from the 20q13 amplicon and their uses | Emerging Cross-Sectional Technologies | 1 | Active |
| US8993251B2 | Genes from 20q13 amplicon and their uses | Emerging Cross-Sectional Technologies | 0 | Active |
| US9790500B2 | Dual targeting antisense oligonucleotides as apoptotic inhibtor therapeutic compostions and methods for their use in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US8685929B2 | Detecting CYP24 expression level as a marker for predisposition to cancer | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.